Egis revenue going high

Shareholders of Hungarian drug maker Egis, majority-owned by France’s Servier, approved payment of a HUF 120-per-share dividend on after-tax profit from the business year ended September 30 at an annual general meeting on Wednesday.

Egis has paid a HUF 120-per-share dividend for years. The dividend fund comes to HUF 934m. The remaining HUF 15.7bn of after-tax profit will be place into profit reserves.CFO Csaba Poroszlai said 95% of the company’s consolidated revenue of HUF 128.9bn was generated directly by the parent company, while export accounted for 73% of the revenue. Egis introduced eight new products during the business year, Mr Poroszlai added.